Trial Investigating an Immunostimulatory Oncolytic Adenovirus for Cancer

Clinical trial NCT03225989 · COMPLETED

Trial details

NCT number: NCT03225989
Sponsor: Lokon Pharma AB
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Pancreatic Adenocarcinoma Ovarian Cancer Biliary Carcinoma Colorectal Cancer

Start date: 2018-03-01
Primary completion: 2023-08-22
Enrollment: 47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.